SCHEMBL3363647

SCHEMBL3363647

NC(=O)N(c1ccc(-c2cccc3[nH]nc(N)c23)cc1)c1cccc(F)c1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 13/20 0.68
ABL1 P00519 9/20 0.60
KIT P10721 7/20 0.60
FLT3 P36888 7/20 0.60
LCK P06239 5/20 0.60
CSF1R P07333 5/20 0.60
FLT1 P17948 4/20 0.60
LYN P07948 4/20 0.60
SRC P12931 4/20 0.60
BLK P51451 4/20 0.60
FLT4 P35916 3/20 0.60
FYN P06241 2/20 0.60
FGFR1 P11362 3/20 0.59
PRKACA P17612 3/20 0.59
ROCK1 Q13464 3/20 0.59
NTRK1 P04629 2/20 0.59
MET P08581 2/20 0.59
GSK3A P49840 2/20 0.59
GSK3B P49841 2/20 0.59
RPS6KA3 P51812 2/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3392985 0.91 KDR (0.72) KDRABL1KITFLT3LCK
SCHEMBL27657352 0.89 KDR (0.66) KDRABL1KITFLT3LCK
SCHEMBL4739859 0.88 KDR (0.63) KDRABL1KITFLT3LCK
SCHEMBL27636446 0.88 KDR (0.64) KDRABL1KITFLT3LCK
SCHEMBL1702897 0.88 KDR (0.53) KDRABL1KITFLT3LCK
SCHEMBL27657299 0.87 KDR (0.65) KDRABL1KITFLT3LCK
SCHEMBL4739562 0.87 KDR (0.74) KDRABL1KITFLT3LCK
SCHEMBL4740070 0.87 KDR (0.62) KDRABL1KITFLT3LCK
SCHEMBL27825044 0.87 KDR (0.76) KDRABL1KITFLT3LCK
SCHEMBL4784983 0.87 KDR (0.62) KDRABL1KITFLT3LCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1826324-B indazole, Benzisoxazole and benzisothiazole kinase inhibitors ABBOTT LABORATORIES (US) 2011-12-07 CN claimed
EP-1638941-B1 INDAZOLE, BENZISOXAZOLE, AND BENZISOTHIAZOLE KINASE INHIBITORS ABBOTT LAB (US) 2010-06-02 EP claimed
WO-2008080110-A1 METHODS FOR TREATING MACULAR EDEMA AND PATHOLOGIC OCULAR ANGIOGENESIS USING A NEUROPROTECTIVE AGENT AND A RECEPTOR TYROSINE KINASE INHIBITOR ALCON, INC. (CH) 2008-07-03 WO claimed
CN-1826324-A Indazole, benzisoxazole and benzisothiazole kinase inhibitors ABBOTT LAB (US) 2006-08-30 CN claimed
CN-102417487-A Indazole, benzisoxazole and benzisothiazole kinase inhibitors ABBOTT LAB 2012-04-18 CN disclosed
CN-1826324-B indazole, Benzisoxazole and benzisothiazole kinase inhibitors ABBOTT LABORATORIES (US) 2011-12-07 CN disclosed
CN-101827584-A Solid dispersion product of N-aryl ureido drugs ABBOTT GMBH & CO KG 2010-09-08 CN disclosed
CN-1826324-A Indazole, benzisoxazole and benzisothiazole kinase inhibitors ABBOTT LAB (US) 2006-08-30 CN disclosed